unc-13 homolog D
Senast uppdaterad 8 maj 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den UNC13D gene provides instructions for making a protein that is involved in the process of cell destruction (cytolysis) and the regulation of the immune system.
Videoval för GenesVideobibliotek
Normal function
Den UNC13D gene provides instructions for making a protein that is involved in the process of cell destruction (cytolysis) and the regulation of the immune system.
The UNC13D protein is involved in the release of substances from cells (exocytosis). In particular, it is important for the exocytosis of structures called cytolytic granules from immune cells called T cells and NK cells. T cells and NK cells destroy other cells by secreting these cytolytic granules, which contain cell-killing proteins, onto the membranes of the target cells. The UNC13D protein helps transport these granules to the membrane of the target cell, allowing cytolytic proteins to enter the cell and trigger it to self-destruct.
This cytolytic mechanism also helps regulate the immune system by destroying unneeded T cells. Controlling the number of T cells prevents the overproduction of immune proteins called cytokines that lead to inflammation and which, in excess, cause tissue damage.
Conditions referring to this gene or chromosome
Other names
FHL3
HLH3
HPLH3
Munc13-4
UN13D_HUMAN
Related patient information and medicines

Patient information leaflet
Kolesteatom
Cholesteatoma is the name given to a collection of skin cells that form a pearly-white greasy-looking lump deep in the ear, usually at the top of the area behind the eardrum. A cholesteatoma is a non-cancerous abnormal growth of skin-like tissue in the middle ear. This condition is uncommon. Around 7-13 people per 100,000 of the population will be.

Patient information leaflet
Graviditetsscreeningtester
It can develop into a serio... It can be treated with antibiotics. Diabetes. If you have had a history of diabetes in a previous pregnancy ( gestational diabetes Diabetes and pregnancy ) then you will be tested for diabetes by a blood test in future pregnancies. In addition, you may be offered a test for diabetes if you have risk factors for.

Patient information leaflet
BRCA-gener
There are a few known gene changes (mutations) that can increase the risk of certain cancers, and tests available for some of them, including BRCA1 och BRCA2 gene mutations. Men with a BRCA1 or BRCA2 mutation have an increased risk of prostate... Breast cancer About 13 in 100 women will develop breast cancer sometime during their lives. Some.

Patient information leaflet
Preventivmetoder
For the example of injections, between 3 och 60 women out of every 1,000 using this method will fall pregnant. When no contraception is used, around 85 in 100 sexually active women become pregnant within one year. The effectiveness of some methods depends on how you use them. T... Between 3 and 60 women in every 1,000 using it will become.

Patient information leaflet
Screening för Downs syndrom
As mentioned above, every woman has a chance of having a baby with Down's syndrome. A screening test is offered to all women in the UK during early graviditeten to look at the chance in this pregnancy of the baby being born with Down's syndrome. It is important to understand that the Down's syndrome screening test does not give a definite 'yes' or.

Patient information leaflet
Testikeltorsion
När a testicle (testis) twists around in the scrotum, the condition is called testicular torsion. An emergency operation is usually needed to treat this condition. What is testicular torsion. If... Musculature and inner workings of the scrotum Musculature and inner workings of the scrotum How common is testicular torsion. Testicular torsion.
Vidare läsning och referenser
- unc-13 homolog D; MedlinePlus, National Library of Medicine.
- Cetica V, Pende D, Griffiths GM, Arico M. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica. 2010 Apr;95(4):538-41. doi: 10.3324/haematol.2009.019562. No abstract available.
- Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):410-5. doi: 10.1097/01.all.0000246626.57118.d9.
- Horne A, Ramme KG, Rudd E, Zheng C, Wali Y, al-Lamki Z, Gurgey A, Yalman N, Nordenskjold M, Henter JI. Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis. Br J Haematol. 2008 Oct;143(1):75-83. doi: 10.1111/j.1365-2141.2008.07315.x. Epub 2008 Aug 15.
- Pivot-Pajot C, Varoqueaux F, de Saint Basile G, Bourgoin SG. Munc13-4 regulates granule secretion in human neutrophils. J Immunol. 2008 May 15;180(10):6786-97. doi: 10.4049/jimmunol.180.10.6786.
- Rudd E, Bryceson YT, Zheng C, Edner J, Wood SM, Ramme K, Gavhed S, Gurgey A, Hellebostad M, Bechensteen AG, Ljunggren HG, Fadeel B, Nordenskjold M, Henter JI. Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. J Med Genet. 2008 Mar;45(3):134-41. doi: 10.1136/jmg.2007.054288. Epub 2007 Nov 9.
- Santoro A, Cannella S, Trizzino A, Bruno G, De Fusco C, Notarangelo LD, Pende D, Griffiths GM, Arico M. Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3. Haematologica. 2008 Jul;93(7):1086-90. doi: 10.3324/haematol.12622. Epub 2008 May 19.
- Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, Binstadt BA, Filipovich A, Grom AA. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 2008 Sep;58(9):2892-6. doi: 10.1002/art.23734.
- Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat. 2006 Jan;27(1):62-8. doi: 10.1002/humu.20274.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
8 maj 2023 | Senaste versionen
1 Jan 2011 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

